GE HealthCare (GEHC) reported third-quarter 2026 revenue of $5.513 billion, up 7.2% from a year earlier. Net income was $623 million, while net income attributable to GE HealthCare was $615 million, compared with $446 million in the prior-year quarter.
Diluted earnings per share were $1.36, up from $0.98 a year earlier. The company raised its full-year 2026 outlook for organic revenue growth and adjusted EPS.
- Third-quarter organic revenue growth was 6.2%; organic orders grew 4.0%.
- Advanced Imaging Solutions revenue was $3.873 billion, Pharmaceutical Diagnostics revenue was $846 million, and Patient Care Solutions revenue was $793 million.
- Cash flow from operating activities totaled $907 million; capital expenditures were $114 million.
- GE HealthCare declared a quarterly dividend of $0.04 per share, up 14% from the prior quarter.
- The company expects 2026 organic revenue growth of about 4.0% and adjusted EPS of $4.95 to $5.05.
$GEHC Insider Trading Activity
$GEHC insiders have traded $GEHC stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GEHC stock by insiders over the last 6 months:
- H LAWRENCE JR CULP purchased 80,805 shares for an estimated $5,000,076
- KEVIN LOBO purchased 10,000 shares for an estimated $641,800
- PETER J ARDUINI (President and CEO) purchased 4,169 shares for an estimated $249,827
- JAMES SACCARO (Chief Financial Officer) purchased 3,310 shares for an estimated $200,585
- FRANK R JIMENEZ (GC & Corporate Secretary) purchased 1,750 shares for an estimated $105,787
- RODNEY F HOCHMAN purchased 1,618 shares for an estimated $100,364
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$GEHC Hedge Fund Activity
We have seen 513 institutional investors add shares of $GEHC stock to their portfolio, and 614 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 20,714,605 shares (-98.1%) from their portfolio in Q2 2026, for an estimated $1,325,941,866
- INVESCO LTD. added 10,558,042 shares (+136.4%) to their portfolio in Q2 2026, for an estimated $675,820,268
- JPMORGAN CHASE & CO added 10,329,164 shares (+inf%) to their portfolio in Q2 2026, for an estimated $661,169,787
- DODGE & COX added 6,552,100 shares (+20.9%) to their portfolio in Q2 2026, for an estimated $419,399,921
- CANADA PENSION PLAN INVESTMENT BOARD removed 3,872,701 shares (-77.8%) from their portfolio in Q2 2026, for an estimated $247,891,591
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 3,129,530 shares (+inf%) to their portfolio in Q2 2026, for an estimated $200,321,215
- TRIAN FUND MANAGEMENT, L.P. added 3,081,300 shares (+76194.4%) to their portfolio in Q2 2026, for an estimated $197,234,013
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
